I watched the post go live on X and saw the mood in Westminster change in real time. A 22-point manifesto by Alex Karp landed like a thrown pebble in the pond of U.K. public contracts. You can feel the contracts teetering as MPs start to name-check breach points and break clauses.
I’m going to walk you through what happened, why it matters, and what you should watch for next. You know the players—Palantir, Alex Karp, Peter Thiel—and you know the stage: the National Health Service, Parliament, and the platforms carrying the debate. Read on if you want the parts that matter without the noise.
MPs watched the manifesto spread across social feeds within hours
The original post on X is a 22-point summary of The Technological Republic: Hard Power, Soft Belief, and the Future of the West, co-written by Karp. It doesn’t read like corporate copy; it reads like a policy primer that picks sides. That bluntness is the problem: if you’re chasing government work in another country, telling that country you think Silicon Valley “owes a moral debt” to the U.S. is the kind of political brand placement that makes officials nervous.
Conservative and Liberal Democrat MPs publicly denounced the thread. Martin Wrigley, a Liberal Democrat member of the Commons science and technology select committee, called the post either “a parody of a RoboCop film” or “a disturbing narcissistic rant,” and said Palantir’s ethos did not suit projects that touch citizens’ most sensitive data. Victoria Collins, another Liberal Democrat, described the writing as the “ramblings of a supervillain.” These aren’t idle insults; they’re reputational accelerants inside Whitehall and across committee rooms.
What did Alex Karp’s manifesto say?
In short: defend the West, repay a perceived moral debt to the U.S., accept hard power and soft cultural hierarchy, and prepare for inevitable AI weaponization. The thread argued Silicon Valley has a duty in matters from violent crime to national service, and it floated the idea of moving away from an all-volunteer military. On X, those notes read less like a corporate mission and more like a geopolitical playbook—and that’s exactly why officials in London took notice.
The NHS is sitting on a seven-year contract worth hundreds of millions
Palantir has secured more than £500 million (~€575 million) in U.K. contracts, including a £330 million (~€380 million) deal with the NHS. Public servants are now asking whether the manifesto changes the political calculus around those agreements.
At Westminster Hall, Junior Health Minister Zubir Ahmed flagged a break clause set for next spring. “My north star is always patient safety and quality, and of course, value for money,” he said—language that points to a practical decision process rather than grandstanding. If the government finds a better supplier at that point, it will be on the table. That’s the financial risk: millions of euros worth of procurement can be reshaped by political optics and procurement review cycles.
Will the NHS cancel Palantir’s contract?
Possibly—but it’s not automatic. Contracts include performance reviews and break clauses. Officials have said they will consider patient safety, quality, and value for money. Critics point to user complaints and limited IP rights; supporters point to operational wins. The decision will hinge on demonstrable outcomes within the NHS tech stack, procurement timelines, and political appetite in the run-up to the break clause.
On the ground, civil servants and clinicians are reporting friction with the platform
Several NHS teams have described the system as hard to use. The Register reported colleagues calling the platform “awful,” and there are repeated gripes about limited control and missing intellectual property for NHS users. Those are practical objections that procurement teams take seriously.
Palantir will point you to cases where its tools sped up diagnoses, kept naval vessels mission-ready, and supported domestic-violence interventions. The company stresses that 17 percent of its workforce is based in the U.K., and it highlights products like Foundry and Gotham as operational successes. But technical wins don’t erase political questions about allegiance when a CEO’s public philosophy places national loyalty front and center.
Think of the manifesto as a brass knuckle in a velvet glove: it’s polished prose wrapped around aggressive geopolitical posture. That tension is why technologists, ministers, and opposition MPs are all now paying attention.
Does Palantir pose risks to U.K. data privacy and sovereignty?
There are two layers to that question: legal compliance and perceived operational control. Legally, Palantir must meet U.K. data protections and contractual obligations. Perception-wise, the manifesto raises doubts about where a company’s loyalties lie—an important factor when health records and national security are involved. Audits, IP clauses, and transparency controls will matter as much as public statements.
Parliamentary pressure changes the procurement mood
When MPs publicly question a supplier, procurement teams start looking harder at alternatives and break clauses. The Guardian and The Register amplified the controversy; social platforms like X and outlets such as Gizmodo carried the company’s rebuttal. That amplification accelerates review timelines and increases political cost for sticking with a controversial partner.
I can tell you this: if you’re working inside government procurement, reputational volatility is now part of the risk ledger. If you’re watching from the outside, notice how quickly a CEO’s public posture can convert into budgetary and operational decisions.
So what happens next? Palantir will have to demonstrate clear, measurable value inside the NHS and other U.K. contracts, and it will have to do so while a chorus of MPs, journalists, and civil servants scrutinise both product performance and corporate ethos. If you had to place a bet, would you back a company whose CEO wrote a manifesto and then wondered why it caused a political storm?